Fibroblast Growth Factor 23 (FGF23) is an Early Specific Marker in the Diagnosis and Staging of Chronic Kidney Disease (CKD) in Human
Radwa M. Mohamed, Eman S. El-Hadidi, Osama M. Ahmed & Wael M. El-Sayed · Journal of Pharmaceutical Research International · 2021
Objective: To evaluate the clinical utility of serum FGF23 as an early specific biomarker in the diagnosis and progression of chronic kidney disease (CKD) patients. Methods: A number of 120 male patients with CKD who were classified according to the eGFR into four stages (n=30 fo...
Open access
Research Article
10.9734/jpri/2021/v33i60B34950